In Colorado, cannabis sales fell 2.4% in Q1 to $283 million, continuing an annual downtrend since the 2021 pandemic spike but showing a smaller drop this quarter. State data released by the Colorado Department of Revenue report that recreational dispensaries sold $283 million in January through March 2026, down from $290 million in Q1 2025.
The 2.4% decline follows multiple years of lower first-quarter totals after the COVID-19 lockdown produced record demand. Q1 2021 remains the all-time high at $453 million, up 29% from $352 million in Q1 2020. Recreational cannabis sales in Colorado grew rapidly in the industry’s first six years after 2014, with a median annual growth rate of 38% over that period.
Toby Ripsom, a Colorado cannabis entrepreneur who co-founded the now-defunct wholesaler Veritas Fine Cannabis and later launched edible maker Flower Union and the skincare brand Galyna, interprets the recent numbers as normalization. He says the market is shifting from pandemic-driven excess toward typical consumer patterns: license counts and consumer prices ballooned through 2021, then producers and retailers built capacity that now exceeds current demand.
“It’s cannabis just being in the mix of every other industry,” Ripsom said, adding that sales volumes are returning to more normal seasonal and economic patterns. He cited two practical factors behind subdued dispensary traffic: household budget pressure and the industry’s reliance on cash transactions.
Ripsom pointed to tighter household budgets as a direct cause of reduced dispensary visits. When consumers cut discretionary spending, purchases such as cannabis are often among the first to decline. He used a concrete example: consumers who have reduced driving to save on fuel are also visiting dispensaries less frequently.
The cash-only nature of many cannabis transactions compounds that effect. Ripsom noted that mainstream payment options and buy-now-pay-later services such as Affirm are unavailable for many cannabis purchases, which can push the category down consumers’ priority list when wallets are tight.
Colorado’s first-quarter figures have fallen each year since the pandemic peak, and the 2.4% Q1 drop in 2026 is smaller than some prior annual declines, suggesting the rate of contraction has slowed. Still, Ripsom said the market has not yet reached a stable plateau and remains affected by the legacy of the 2020–2021 surge: an expanded license network and higher prices created an oversupply relative to current demand.
Data points: – Q1 2026 recreational sales: $283 million – Q1 2025 recreational sales: $290 million (-2.4%) – Q1 2021 recreational sales: $453 million (all-time high) – Q1 2020 recreational sales: $352 million (+29% to 2021 peak) – Median annual growth 2014–2019: 38%
Analysts and operators cite clear, measurable drivers behind the figures: a demand spike during pandemic restrictions, subsequent increases in producer and retailer capacity, and current consumer spending pressure. Those factors have combined to reduce year-over-year first-quarter sales totals since 2021.
For dispensaries, the mix of cash handling, limited access to mainstream payment rails, and narrower discretionary spending among consumers creates operational and revenue challenges. Operators that can adjust pricing, diversify product lines, or find ways to improve payment convenience where legally possible may preserve sales volume. Ripsom emphasized that the shift looks less like collapse and more like a return to pre‑boom business dynamics.
Outlook: Colorado’s recreational cannabis market appears to be moving toward steadier patterns after the pandemic surge. The latest quarter shows a modest decline rather than a sharp drop, but continued pressure on household budgets and persistent payment limitations mean dispensary revenues could remain constrained until consumer spending recovers or payment options expand.
Source: Colorado Department of Revenue; reporting and comments from cannabis entrepreneur Toby Ripsom. Additional coverage available from BusinessDen.
